Bank of Ireland: The retreat in financial stocks around Europe saw the bank shares fall 3.5 per cent to €0.27. Photograph: Frantzesco Kangaris/Bloomberg

European shares fell sharply yesterday as disappointing economic data from the US further undermined sentiment already hurt by weak earnings updates. (...)

Michael McKenna, chairman, and John Fox, chief executive, at the Merrion Pharma egm. Photograph: Cyril Byrne

Shareholders in Merrion Pharma have approved the sale of some IP assets to partner Novo Nordisk and the transformation of the company into an investme(...)

Gareth Jones recalls witnessing a scene in a Dublin pub when a man fired a shoe at a TV screen at the announcement of the second AIB bank bailout. “Th(...)

 Merrion Pharmaceuticals chief executive Dr John Fox

Merrion Pharmaceuticals says its survival is dependent on Declan Ryan’s Irelandia Investments not calling in an overdue loan as it reported a doubling(...)

Drugmaker Novo Nordisk demoted company president Kaare Schultz 15 months after putting him in line to become the next chief executive, prompting him t(...)

Bank of Ireland gained 1.35 per cent to close the day at 37.5 cents. Its chief executive, Richie Boucher, said the bank would in future look to grow in the UK through bolt-on acquisitions, though he indicated there were no immediate plans. Photograph: Aidan Crawley

European stocks rose yesterday, trimming their worst weekly loss of the year, as the Stoxx Europe 600 Index added 0.3 per cent. The market in Dubli(...)

Traders work at their screens in front of the German share price index DAX board at the stock exchange in Frankfurt yesterday. Photograph: Pawel Kopczynski/Reuters

Markets rose amid hopes that the European Central Bank’s (ECB) €1.14 trillion stimulus plans will spark economic growth in the region.Analysts said t(...)

The upward Iseq movement was helped by a 2.55% climb for one of its biggest stocks, Ryanair. Photograph: Alan Betson / The Irish Times

Concern about the outcome of a Greek election is likely to translate into weeks of nervous equity markets across the euro zone, analysts forecast.Eur(...)

 Dr John Fox, chief executive, Merrion Pharmaceuticals. Photograph: Eric Luke / The Irish Times

Merrion Pharmaceuticals has blamed foreign exchange weakness for a 4 per cent fall in revenues in the first half of the year.The Irish group’s revenue(...)

Merrion Pharmaceuticals chief executive John Fox. Photograph: Eric Luke

Merrion Pharma is back on the active list. The Elan spin-off which effectively went into hibernation during the recession has re-emerged this year un(...)